194 related articles for article (PubMed ID: 37291428)
61. Watch and Wait Strategy for Rectal Cancer: How Long Should We Wait for a Clinical Complete Response?
Asoglu O; Goksoy B; Aliyev V; Mustafayev TZ; Atalar B; Bakir B; Guven K; Demir G; Goksel S
Surg Technol Int; 2022 May; 40():130-139. PubMed ID: 35090178
[TBL] [Abstract][Full Text] [Related]
62. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
[TBL] [Abstract][Full Text] [Related]
63. [Principle of surgical management for rectal cancer patients with complete clinical response after neoadjuvant therapy].
Li XX; Luo DK
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):342-348. PubMed ID: 31054548
[TBL] [Abstract][Full Text] [Related]
64. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
[TBL] [Abstract][Full Text] [Related]
65. Nonoperative Management or 'Watch and Wait' for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal.
Sammour T; Price BA; Krause KJ; Chang GJ
Ann Surg Oncol; 2017 Jul; 24(7):1904-1915. PubMed ID: 28324284
[TBL] [Abstract][Full Text] [Related]
66. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.
Jia AY; Narang A; Safar B; Zaheer A; Murphy A; Azad NS; Gearhart S; Fang S; Efron J; Warczynski T; Hacker-Prietz A; Meyer J
Radiat Oncol; 2019 Aug; 14(1):147. PubMed ID: 31426827
[TBL] [Abstract][Full Text] [Related]
67. [Complete response after neoadjuvant therapy: how certain is radiology?].
Kuzior H; Eisenblätter M
Chirurg; 2022 Feb; 93(2):123-131. PubMed ID: 34936002
[TBL] [Abstract][Full Text] [Related]
68. [Evaluation strategy of complete response after neoadjuvant therapy for rectal cancer].
Han JG; Wang ZJ
Zhonghua Wai Ke Za Zhi; 2023 Sep; 61(9):738-743. PubMed ID: 37491164
[TBL] [Abstract][Full Text] [Related]
69. Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial.
Gérard JP; Chamorey E; Gourgou-Bourgade S; Benezery K; de Laroche G; Mahé MA; Boige V; Juzyna B
Radiother Oncol; 2015 May; 115(2):246-52. PubMed ID: 25921382
[TBL] [Abstract][Full Text] [Related]
70. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
[TBL] [Abstract][Full Text] [Related]
71. Long-term imaging characteristics of clinical complete responders during watch-and-wait for rectal cancer-an evaluation of over 1500 MRIs.
Lambregts DMJ; Maas M; Boellaard TN; Delli Pizzi A; van der Sande ME; Hupkens BJP; Lahaye MJ; Bakers FCH; Beets GL; Beets-Tan RGH
Eur Radiol; 2020 Jan; 30(1):272-280. PubMed ID: 31428827
[TBL] [Abstract][Full Text] [Related]
72. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.
Tan S; Gao Q; Cui Y; Ou Y; Huang S; Feng W
Int J Colorectal Dis; 2023 Oct; 38(1):246. PubMed ID: 37787779
[TBL] [Abstract][Full Text] [Related]
73. [Transition of treatment strategy for locally advanced rectal cancer towards "watch and wait"].
Xiao WW; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):514-520. PubMed ID: 31238631
[TBL] [Abstract][Full Text] [Related]
74. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.
Santiago I; Barata M; Figueiredo N; Parés O; Henriques V; Galzerano A; Carvalho C; Matos C; Heald RJ
Eur Radiol; 2020 Jan; 30(1):224-238. PubMed ID: 31350587
[TBL] [Abstract][Full Text] [Related]
75. [The importance of radiotherapy in rectal cancer-an update from a surgeon's perspective].
Lauscher JC; Schineis CHW; Weixler B; Kreis ME
Chirurg; 2021 Jul; 92(7):591-598. PubMed ID: 33893541
[TBL] [Abstract][Full Text] [Related]
76. Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy: The Impact of Radiation Therapy Dose-escalation and Consolidation Chemotherapy.
Habr-Gama A; São Julião GP; Vailati BB; Sabbaga J; Aguilar PB; Fernandez LM; Araújo SEA; Perez RO
Ann Surg; 2019 Jan; 269(1):102-107. PubMed ID: 28742703
[TBL] [Abstract][Full Text] [Related]
77. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI.
Zhang XY; Wang L; Zhu HT; Li ZW; Ye M; Li XT; Shi YJ; Zhu HC; Sun YS
Radiology; 2020 Jul; 296(1):56-64. PubMed ID: 32315264
[TBL] [Abstract][Full Text] [Related]
78. Outcomes after the watch-and-wait strategy and local excision treatment for rectal cancer: a meta-analysis.
Li J; Ma Y; Wen L; Zhang G; Yao X
Expert Rev Anticancer Ther; 2023 May; 23(5):555-564. PubMed ID: 36795784
[TBL] [Abstract][Full Text] [Related]
79. [Interpretation of consensus on the watch and wait strategy in rectal cancer patients after neoadjuvant treatment (2020)].
Zhao YM; Wang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):237-242. PubMed ID: 32192301
[TBL] [Abstract][Full Text] [Related]
80. Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer.
van der Sande ME; Maas M; Melenhorst J; Breukink SO; van Leerdam ME; Beets GL
Ann Surg; 2021 Dec; 274(6):e541-e547. PubMed ID: 31851000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
